DIFFERENTIAL EFFECTS OF SMOKING ON LONG-TERM OUTCOMES IN PATIENTS WITH ATHEROSCLEROTIC VASCULAR DISEASE TREATED WITH ASPIRIN OR CLOPIDOGREL: INSIGHTS FROM THE CLOPIDOGREL VERSUS ASPIRIN IN PATIENTS AT RISK OF ISCHEMIC EVENTS TRIAL | Publicación